Quel est le prix pour DermTech, Inc. (DMTK)

Le prix pour DermTech, Inc. (DMTK) est $0.069

Quelle est la capitalisation boursière pour DermTech, Inc. (DMTK)

La capitalisation boursière pour DermTech, Inc. (DMTK) est $2.06M

Bénéfices de DermTech, Inc. (DMTK)

DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.

Année	Bénéfices	Changez
2026 (TTM)	$-89.63M	-11.16%
2023	$-100.89M	-13.54%
2022	$-116.68M	48.95%
2021	$-78.34M	114.75%
2020	$-36.48M	85.27%
2019	$-19.69M	-2,184.69%
2018	$944.46K	-1,574,196.67%
2017	$-60.00	-100.00%
2013	$-5.18M	132.41%
2012	$-2.23M	0.00%

Année

Bénéfices

Changez

2026 (TTM)

$-89.63M

-11.16%

2023

$-100.89M

-13.54%

2022

$-116.68M

48.95%

2021

$-78.34M

114.75%

2020

$-36.48M

85.27%

2019

$-19.69M

-2,184.69%

2018

$944.46K

-1,574,196.67%

2017

$-60.00

-100.00%

2013

$-5.18M

132.41%

2012

$-2.23M

0.00%

Entreprise	Bénéfices	Différence de bénéfices	Pays
Thermo Fisher Scientific Inc. TMO.US	$7.61B	-8,589.53%	US
Danaher Corporation DHR.US	$4.76B	-5,413.07%	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	$-252.70M	181.94%	US
IDEXX Laboratories, Inc. IDXX.US	$1.42B	-1,689.26%	US

Entreprise

Bénéfices

Différence de bénéfices

Pays